Why value “measurement” is critical to the future of the meetings industry development

Isabel Bardinet, CEO ESC

JMIC, Paris, May 2015

Speaker

The European society of Cardiology

• To reduce the burden of cardiovascular disease in Europe

ESC - European Society of Cardiology

• 1950: ESC founded by 14 National Societies

• 1952: First European Congress of Cardiology

• Since 1985: Centralised association administration and Congress organisation

• 1993: European Heart House built as official headquarters

ESC National Cardiac Societies

ESC Affiliated Cardiac Societies

56 NCS ( 90 000 members )38 affiliated societies6 Associations 5 Councils 15 Working Groups ESC Fellows and Nurse Fellows

Speaker

How does the ESC interact with the Meetings Industry ?

• Congress organisation - a direct value

• ESC activities - indirect driving value

• Cardiovascular Disease – a societal factor

Speaker

Direct Impact Metrics Usually Considered

Number of

• Congress participants and countries • Sessions• Abstracts • Rooms • Sqm• Days • Hotel nights

ESC congress 2014

• Abstracts submitted• Abstracts selected• Lecture rooms• Number of sessions• Expo m² occupied• Total sqm occupied• Satellite Symposia• Hands on Tutorials• Active Delegates• Total Attendance

• 11 444• 4 597• 31• 521• 10 369• 100 000• 70• 4• 24 622• 30 330

Speaker

ESC Primary Activities

• Education & Scientific resourcesJournals, publications, courses and leading European congresses

• Membership National Cardiac Societies, Associations, Working Groups, Councils, Fellowsof the ESC (FESC)

• Surveys and registriesEURObservational Research Programme - reliable data collection on CVD

• Clinical Practice GuidelinesRecommendations for diagnosis & therapy

• European Affairs Political Advocacy, European Union, Health Organisations

• Global Affairs Increase outreach and impact with international organisations

Indirect Driving Factors

• Education & Scientific resources12 Journals, European Heart Journal is the flagship N°2 with IF 14.7 3500 manuscripts per annum with a 12% acceptance rate Publications 4 textbooks , handbooks Distance learning platform and webinar courses

• Membership 90,000 Members 56 National Cardiac Societies, 6 Associations, 15 Working Groups 5 Councils, Fellows and Nurse Fellows and 38 affiliated societies

• Late breaking clinical trials this year 233 for 70 accepted

• Clinical practice Guidelines 1.2 million downlaods in 2014 Recommendations for diagnosis /therapy clarify areas of consensus and

disagreement, allowing distribution of the best possible guidance to practicing physicians 4 to 5 published per year

Speaker

Indirect Driving Factors

• RegistriesRegistries are essential to assess CV epidemiology, diagnostic/therapeutic processes and adherence to Guidelines.

20 different registries Over 1 000 centres with 70 000 patients More than 100 publications Over 70 countries already participating

• Certification / Revalidation• The ESC offers cardiology practitioners a range of certifications to test and

assess their knowledge, skills and performance in their practice following post-graduation, educational and training experiences.

• ESC certifications are both a proof of professional excellence to the patients and a way for practitioners to enhance their good practice.

• Health economics – outcome measurement

Speaker

Societal factors

• All of these activities are driven by societal factors

Speaker

European CVD Statistics 2012

  Each year cardiovascular disease causes over 4 million deaths in Europe and over 1.9 million deaths in the European Union (EU).

  CVD causes 47% of all deaths in Europe

and 40% in the EU.   CVD is the main cause of death in women

in all countries of Europe and is the main cause of death in men

Speaker

CVD Health Industry in Europe

• Overall CVD is estimated to cost the EU economy almost €196 billion a year.

• Of the total cost of CVD in the EU, around 54% is due to health care costs, 24% due to productivity losses and 22% due to the informal care of people with CVD.

Global Distribution of Deaths from Non-Communicable Diseases

Cumulative Contribution to Life Expectancy Increase, 1970–2000

Speaker

CVD Health Industry Worldwide

• Economists project that the cost of not investing in CVD prevention and treatment could amount to as much as $47 trillion worldwide in the next 25 years.

• This loss is potentially avoidable because the prescribed World Health Organization (WHO) “best buy” interventions only cost $11 billion to $13 billion annually. The consequences will be more severe in developing countries, given that 80% of cardiovascular deaths occur in LMIC countries .

Projected economic loss of NCDs in LMIC countries worldwide, 2011 to 2025

ESC congress 2014

• Abstracts submitted• Abstracts selected• Lecture rooms• Number of sessions• Expo m² occupied• Total sqm occupied• Satellite Symposia• Hands on Tutorials• Active Delegates• Total Attendance

• 11 444• 4 597• 31• 521• 10 369• 100 000• 70• 4• 24 622• 30 330

Value driving factors Measurement or assessment ?

• Value for whom?

• Meetings Industry• Association /organiser• Society

• But above all value coming from where ? • => value assessment criteria

• These should not be restricted to the meetings industry criteria

Speaker

No more coffee cups and hotel beds please !!

Speaker

Value assessment for the meetings industry

• You can have a Passive or an interactive attitude :

• Wait and see what comes or observe and adapt

• But to adapt you need to know to show and to project

”The great thing in this world is not so much where we stand as in what direction we are

moving”

Oliver Wendell Holmes1841-1935

Speaker

• Thank you for your attention and for the opportunity of presenting

our side of the iceberg !